This is a skin condition that causes repeating red, scaly patches that move around. It's often linked to a rare type of tumor that makes too much glucagon, a hormone. Sometimes, other conditions can cause similar skin changes.
Every report comes from a Lived member, sent anonymously.
Have you tried Octreotide for Necrolytic Migratory Erythema?
Necrolytic migratory erythema (NME) is a distinctive, painful and itchy rash that comes and goes and moves around the body. Patches start as red rings or plaques that blister, break open and crust, then heal in the center while the edges spread. It most often appears around the groin, genitals and buttocks, on the lower legs and around the mouth. A sore, smooth tongue, cracked lips at the corners of the mouth and brittle nails can come with it. The rash matters because of what usually causes it. In most people, NME is a sign of a glucagonoma, a rare tumor of the pancreas that releases too much glucagon, a hormone that raises blood sugar. The rash is often the first noticeable sign of that tumor, so recognizing it can lead to an earlier diagnosis. When the same rash appears without a tumor, it is called pseudoglucagonoma syndrome.
A glucagonoma is a slow-growing neuroendocrine tumor (a tumor of hormone-making cells) that arises in the pancreas. It is very rare, affecting roughly one person in 20 million each year, usually in middle age. The excess glucagon pushes the body into a state of breaking down its own protein and fat. That uses up amino acids (the building blocks of protein), zinc and essential fatty acids, and the skin seems to suffer from these shortages, although exactly how the rash forms is not fully understood. The same process explains the other features of glucagonoma syndrome: diabetes or high blood sugar, weight loss, anemia, diarrhea, a higher tendency to form blood clots and, in some people, depression or other mood and neurological changes. Most glucagonomas occur by chance. A small share are inherited, mainly as part of multiple endocrine neoplasia type 1 (MEN1), a genetic condition that causes tumors in several hormone glands. Pseudoglucagonoma syndrome produces the same rash without a glucagonoma. It has been linked to liver disease and cirrhosis, conditions that block absorption of nutrients (such as celiac disease, Crohn's disease and cystic fibrosis), severe malnutrition, heavy alcohol use, pancreatitis and zinc deficiency.
NME is frequently mistaken for eczema, psoriasis, a fungal infection or another form of dermatitis. Because the rash fades and returns, and because glucagonoma is so rare, the correct diagnosis often comes years after the first symptoms. A rash with this pattern that keeps coming back despite usual treatment, especially alongside new diabetes or unexplained weight loss, is a reason to look further. A skin biopsy, in which a small sample of skin is examined under a microscope, can show the characteristic damage and separation in the upper layers of the skin. Blood tests then look for the cause. A blood glucagon level is the key test: in glucagonoma it is usually far above normal. Other tests check blood sugar, blood counts for anemia, liver function, zinc and amino acid levels. If glucagon is high, imaging is used to find the tumor and see whether it has spread. Computed tomography (CT) or magnetic resonance imaging (MRI) scans of the abdomen are standard, and a specialized positron emission tomography (PET) scan that detects somatostatin receptors (a protein many of these tumors carry) can find small tumors and spread elsewhere. Endoscopic ultrasound, a scope passed through the mouth to image the pancreas from inside the stomach, can also help. A biopsy of the tumor confirms the type. If no tumor is found and glucagon is normal or only mildly raised, clinicians look instead for liver disease, malabsorption or nutritional deficiency.
Treatment aims at the cause, not just the skin. For glucagonoma, surgery to remove the tumor is the most effective treatment and the only approach that can cure localized disease. The rash usually clears once the tumor is gone. Even when the tumor has spread, removing as much of it as is safely possible can improve symptoms and may extend survival. While waiting for surgery, or when surgery is not possible, medicines that mimic the hormone somatostatin are the main way to control symptoms. Octreotide (Sandostatin) and lanreotide (Somatuline Depot) are injections that reduce glucagon release, often improving the rash, and they may slow tumor growth. Possible side effects include diarrhea, stomach pain and gallstones. Nutritional support is a direct treatment for the rash. Zinc supplements, amino acid infusions and essential fatty acids can improve the skin, sometimes dramatically, though usually not permanently while the tumor remains active. Diabetes is managed with diet, metformin or insulin as needed, and people with glucagonoma, particularly around surgery, may be given blood thinners to prevent clots. For advanced or spreading tumors, a specialist team may use treatments aimed at the liver (removing, burning or blocking the blood supply to tumor deposits), targeted drugs, chemotherapy or peptide receptor radionuclide therapy, a radioactive treatment that is carried to tumor cells by the same somatostatin receptors seen on the PET scan. In pseudoglucagonoma syndrome, the rash improves when the underlying problem is treated, for example by correcting zinc or protein deficiency or managing liver or bowel disease.
The outlook depends mostly on the underlying cause and, for glucagonoma, on whether the tumor has spread. Glucagonomas grow slowly, but about half have already spread, most often to the liver, by the time they are found, largely because diagnosis is delayed. People whose tumor is found before it spreads and is fully removed usually do very well over the long term. When it has spread, the disease is generally treated as a long-term condition, and many people live for years with a combination of medicines, procedures and nutritional care. The rash tends to wax and wane until the cause is controlled. Painful, open patches can make walking, sitting and wearing clothes uncomfortable, so gentle skin care is part of daily life during flares. Once the tumor is removed, the rash usually clears. Care is usually shared between dermatology, endocrinology, surgery and oncology, ideally at a center experienced with neuroendocrine tumors. Follow-up includes regular blood tests, including glucagon levels, and scans to watch for the tumor returning or growing. A return of the rash can be an early sign that the disease is active again.
See a clinician, ideally a dermatologist, about a red, blistering or crusting rash that keeps moving, returns after treatment or does not respond to usual eczema or fungal creams, especially if you also have new diabetes, weight loss or a sore tongue and mouth. If you have already been treated for glucagonoma, tell your care team if the rash comes back. Glucagonoma raises the risk of blood clots in the veins. Contact your care team right away about new pain, swelling, warmth or redness in one leg or arm. Call 911 for sudden shortness of breath, chest pain that worsens with breathing, coughing up blood or fainting, which can mean a clot has reached the lungs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Necrolytic Migratory Erythema is like, what's helped you, or ask the community a question.